ES8302002A1 - Un procedimiento para la preparacion de nuevos derivados de cefalosporina. - Google Patents
Un procedimiento para la preparacion de nuevos derivados de cefalosporina.Info
- Publication number
- ES8302002A1 ES8302002A1 ES505923A ES505923A ES8302002A1 ES 8302002 A1 ES8302002 A1 ES 8302002A1 ES 505923 A ES505923 A ES 505923A ES 505923 A ES505923 A ES 505923A ES 8302002 A1 ES8302002 A1 ES 8302002A1
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- compositions containing
- cephalosporin derivatives
- groups
- group selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE CEFALOSPORINA Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES METILO O ETILO; R ES HIDROGENO O METILO; Y R ES ALQUILO C <003> O ALCOXI C <003> . CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) O UN DERIVADO REACTIVO DEL MISMO CON UN COMPUESTO DE FORMULA R <024>COOCHR B, EN LAS QUE A ES OXIGENO O =NOR ; R ES AMINO O AMINO PROTEGIDO; R ES HIDROXI Y B ES EL GRUPO DE FORMULA (III) O R ES EL GRUPO DE FORMULA (IV) Y B ES HALOGENO; Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE A LA TEMPERATURA AMBIENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIBACTERIANA.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55136449A JPS5759894A (en) | 1980-09-30 | 1980-09-30 | Cephalosporin for oral administration |
JP5523181A JPS57169489A (en) | 1981-04-13 | 1981-04-13 | Cephalosporin derivative and its preparation |
JP8911681A JPS57206687A (en) | 1981-06-10 | 1981-06-10 | Cephalosporin derivative and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
ES505923A0 ES505923A0 (es) | 1982-12-16 |
ES8302002A1 true ES8302002A1 (es) | 1982-12-16 |
Family
ID=27295533
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES505923A Expired ES8302002A1 (es) | 1980-09-30 | 1981-09-30 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
ES514995A Expired ES8306759A1 (es) | 1980-09-30 | 1982-08-13 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
ES514993A Expired ES8306158A1 (es) | 1980-09-30 | 1982-08-13 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
ES514994A Expired ES8306159A1 (es) | 1980-09-30 | 1982-08-13 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES514995A Expired ES8306759A1 (es) | 1980-09-30 | 1982-08-13 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
ES514993A Expired ES8306158A1 (es) | 1980-09-30 | 1982-08-13 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
ES514994A Expired ES8306159A1 (es) | 1980-09-30 | 1982-08-13 | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. |
Country Status (11)
Country | Link |
---|---|
US (2) | US4486425A (es) |
EP (1) | EP0049118B1 (es) |
KR (1) | KR870000848B1 (es) |
AU (1) | AU547984B2 (es) |
CA (1) | CA1171404A (es) |
DE (1) | DE3174472D1 (es) |
ES (4) | ES8302002A1 (es) |
FI (1) | FI73440C (es) |
IE (1) | IE53177B1 (es) |
NL (1) | NL930098I2 (es) |
PH (1) | PH18740A (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) * | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
US5223496A (en) * | 1987-11-10 | 1993-06-29 | The Upjohn Company | Cephalosporin antibiotics |
JPH01230547A (ja) * | 1988-01-14 | 1989-09-14 | Takeda Chem Ind Ltd | 3−オキソ酪酸第三ブチルの製造法及びその用途 |
DE3804841A1 (de) * | 1988-02-17 | 1989-08-31 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
GB8809534D0 (en) * | 1988-04-22 | 1988-05-25 | Beecham Group Plc | Novel compounds |
DE3901405A1 (de) * | 1989-01-19 | 1990-07-26 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
DE3919259A1 (de) * | 1989-06-13 | 1990-12-20 | Hoechst Ag | Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
YU48484B (sh) * | 1991-05-24 | 1998-09-18 | Hoechst Aktiengesellschaft | Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline |
PT531875E (pt) * | 1991-09-07 | 2004-08-31 | Aventis Pharma Gmbh | Diastereomeros do ester 1-(isopropoxicarboniloxi)-etilico do acido 3-cefem-4-carboxilico e processo para a sua preparacao |
TW212181B (es) * | 1992-02-14 | 1993-09-01 | Hoechst Ag | |
ES2117066T3 (es) * | 1992-05-21 | 1998-08-01 | Hoechst Ag | Procedimiento para la disociacion de esteres profarmacos de cefalosporina para dar acido 7-amino-3-metoximetil-cef-3-em-4-carboxilico. |
LT3870B (en) | 1993-11-30 | 1996-04-25 | Hoechst Ag | Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof |
US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
AT413383B (de) | 1998-01-09 | 2006-02-15 | Sandoz Ag | Verfahren zur isolierung eines diastereoisomerengemisches von cefpodoxim proxetil |
AT408226B (de) * | 1999-05-05 | 2001-09-25 | Biochemie Gmbh | Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2 |
IN191496B (es) | 1999-07-30 | 2003-12-06 | Ranbaxy Lab Ltd | |
KR100342944B1 (ko) * | 1999-11-08 | 2002-07-02 | 민경윤 | 고순도 세프포독심 프록세틸의 제조방법 |
WO2002068429A1 (en) * | 2001-02-27 | 2002-09-06 | Ranbaxy Laboratories Limited | Process for the preparation of cefpodoxime proxetil |
CN1505515A (zh) * | 2001-02-27 | 2004-06-16 | ʵ | 头孢泊肟酯的口服药物组合物 |
KR20040088519A (ko) | 2002-02-22 | 2004-10-16 | 뉴 리버 파마슈티칼스, 인크. | 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법 |
AU2003282267A1 (en) * | 2002-11-22 | 2004-06-18 | Orchid Chemicals And Pharmaceuticals Ltd | An improved process for the preparation of cefpodoxime proxetil |
US20060293296A1 (en) * | 2002-12-20 | 2006-12-28 | Gharpure Milind M | Process for the preparation of cefpodoxime procetil |
GB0301938D0 (en) * | 2003-01-28 | 2003-02-26 | Biochemie Gmbh | Organic compounds |
US20040242863A1 (en) * | 2003-05-27 | 2004-12-02 | Carenini Alessandro Riccardo | Preparation of cefalosporins intermediates and conversion of said intermediates into active compound precursors |
WO2010097675A1 (en) | 2009-02-27 | 2010-09-02 | Dhanuka Laboratories Ltd. | An improved preparation process for cefpodoxime proxetil |
TR201002878A2 (tr) | 2010-04-13 | 2011-10-21 | Bi̇lgi̇ç Mahmut | Sefpodoksim proksetil içeren farmasötik bileşimler. |
WO2011152808A1 (en) | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Formulation comprising cefpodoxime proxetil and clavulanic acid |
EP2575812A2 (en) | 2010-06-03 | 2013-04-10 | Mahmut Bilgic | Pharmaceutical composition comprising cefpodoxime proxetil and clavulanic acid |
TR201007107A1 (tr) | 2010-08-25 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. |
TR201007106A1 (tr) | 2010-08-25 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Sefpodoksim proksetil formülasyonları. |
TR201009168A2 (tr) | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Suda dağılan sefpodoksim proksetil formülasyonları. |
EP2520578A1 (en) | 2011-05-06 | 2012-11-07 | Lupin Limited | Process for purification of cephalosporins |
WO2013041999A1 (en) | 2011-09-20 | 2013-03-28 | Dhanuka Laboratories Ltd. | An improved process for cefpodoxime acid |
WO2013151517A1 (en) | 2012-04-04 | 2013-10-10 | Mahmut Bilgic | Tablet formulations comprising cefpodoxime proxetil and clavulanic acid |
WO2014123500A1 (en) | 2013-02-11 | 2014-08-14 | Bilgiç Mahmut | Pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024137A (en) * | 1971-05-14 | 1977-05-17 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins |
GB1425933A (en) * | 1972-03-13 | 1976-02-25 | Astra Laekemedel Ab | Cephalosporins |
JPS5119765A (en) * | 1974-08-09 | 1976-02-17 | Takeda Chemical Industries Ltd | Aminochiazoorujudotaino seizoho |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
DE2760484C2 (es) * | 1976-04-14 | 1992-12-03 | Takeda Chemical Industries, Ltd., Osaka, Jp | |
JPS53103493A (en) * | 1977-02-18 | 1978-09-08 | Takeda Chem Ind Ltd | Cephalosporin derivatives and process for their preparation |
DE2714880A1 (de) | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
US4409215A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof |
FR2476087A1 (fr) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
-
1981
- 1981-09-23 US US06/304,988 patent/US4486425A/en not_active Expired - Lifetime
- 1981-09-24 EP EP81304415A patent/EP0049118B1/en not_active Expired
- 1981-09-24 DE DE8181304415T patent/DE3174472D1/de not_active Expired
- 1981-09-29 PH PH26288A patent/PH18740A/en unknown
- 1981-09-30 KR KR1019810003696A patent/KR870000848B1/ko active
- 1981-09-30 ES ES505923A patent/ES8302002A1/es not_active Expired
- 1981-09-30 CA CA000387048A patent/CA1171404A/en not_active Expired
- 1981-09-30 AU AU75781/81A patent/AU547984B2/en not_active Expired
- 1981-09-30 IE IE2273/81A patent/IE53177B1/en active Protection Beyond IP Right Term
- 1981-09-30 FI FI813038A patent/FI73440C/fi not_active IP Right Cessation
-
1982
- 1982-08-13 ES ES514995A patent/ES8306759A1/es not_active Expired
- 1982-08-13 ES ES514993A patent/ES8306158A1/es not_active Expired
- 1982-08-13 ES ES514994A patent/ES8306159A1/es not_active Expired
-
1986
- 1986-06-10 US US06/873,114 patent/US4716158A/en not_active Expired - Lifetime
-
1993
- 1993-06-25 NL NL930098C patent/NL930098I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
ES514993A0 (es) | 1983-05-01 |
DE3174472D1 (en) | 1986-05-28 |
ES505923A0 (es) | 1982-12-16 |
KR870000848B1 (ko) | 1987-04-25 |
KR830007685A (ko) | 1983-11-04 |
FI813038L (fi) | 1982-03-31 |
ES514994A0 (es) | 1983-05-01 |
NL930098I1 (nl) | 1993-10-01 |
ES514995A0 (es) | 1983-06-01 |
ES8306759A1 (es) | 1983-06-01 |
AU7578181A (en) | 1982-04-08 |
IE53177B1 (en) | 1988-08-17 |
US4716158A (en) | 1987-12-29 |
EP0049118A3 (en) | 1983-01-19 |
FI73440B (fi) | 1987-06-30 |
PH18740A (en) | 1985-09-16 |
CA1171404A (en) | 1984-07-24 |
ES8306159A1 (es) | 1983-05-01 |
EP0049118B1 (en) | 1986-04-23 |
US4486425A (en) | 1984-12-04 |
AU547984B2 (en) | 1985-11-14 |
EP0049118A2 (en) | 1982-04-07 |
FI73440C (fi) | 1987-10-09 |
NL930098I2 (nl) | 1995-02-01 |
IE812273L (en) | 1982-03-30 |
ES8306158A1 (es) | 1983-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8302002A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
PH23739A (en) | Piperidine derivative and pharmaceutical composition | |
ES8203883A1 (es) | Un procedimiento para la preparacion de derivados de imida- zol | |
ES480542A1 (es) | Metodo para producir derivados de imidazol. | |
ES8607297A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. | |
ATE19878T1 (de) | Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES8302001A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalospirina. | |
IL77452A (en) | Derivatives of arylcyclobutylalkyl-amines,their preparation and pharmaceutical compositions containing them | |
ES486824A1 (es) | Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas | |
ES8403919A1 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
IL69882A (en) | Analgesia-effecting 5-hydroxytryptophan derivatives and pharmaceutical compositions comprising them | |
ES8205791A1 (es) | Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo | |
IL64647A (en) | 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
ES8704460A1 (es) | Un procedimiento para preparar derivados de 2-piridin-tiol | |
ES8207177A1 (es) | Procedimiento para preparar nuevos derivados de triazoloqui-nazolinona | |
ES8406442A1 (es) | Un procedimiento para preparar compuestos de acido quinolilacetico | |
ES8801652A1 (es) | Un procedimiento para la preparacion de un derivado de tiazolidina. | |
ES8307233A1 (es) | Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico. | |
ATE29251T1 (de) | Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ES8403130A1 (es) | Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas. | |
ES8407318A1 (es) | Procedimiento de preparacion de derivados de piperacina. | |
ES8305304A1 (es) | "procedimiento de preparacion de derivados de etanolamina". | |
ES464773A1 (es) | Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos. | |
SE8405338A (sv) | (1,3)oxazino (4,3-a) isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
ES8609288A1 (es) | Un procedimiento para preparar un derivado de tiazolidina |